Abstract
Cervical cancer is the fourth most common cancer among women globally but the second most common in Sub-Saharan Africa (SSA). The high burden of cervical cancer in developing countries reflects the absence of cervical cancer prevention programs. The majority of the incident cases and deaths from cervical cancer, greater than 85 %, occur in developing countries, where resources for early detection and treatment are severely limited. Survival from cancer in Africa is very poor due to late presentation and lack of access to effective treatment. Radiation, chemotherapy, and surgical oncology are not available in many parts of SSA. It is estimated that by 2030 cancer will affect much larger numbers of people living in low- and middle-income countries. Very few, if any, are prepared for or have sufficient health care infrastructure to provide acceptable services. It is imperative that governments in low- and middle-income countries pay urgent attention to the problem by developing National Cancer Control Programs, which should include population-based registries and data collection systems that allow an accurate evaluation of the burden of disease and hence resources required to meet it.
References
GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr. Accessed 28 Sept 2014.
Miller AB. Cervical cancer screening programmes. Managerial Guidelines. Geneva: World Health Organisation; 1992:24–25.
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–9.
Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Keertie, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Eng J Med. 2003;348:518–27.
Sankaranarayanan R, Swaminathan R, Brenner H, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol. 2010;11:165–73.
Gondos A, Brenner H, Wabinga H, Parking DM. Cancer survival in Kampala, Uganda. Br J Cancer. 2005;92(9):1808–12.
Independent Evaluation Group Studies. Annual Review of Development Effectiveness: Achieving Sustainable Development. 2009 World Bank.
Hanna T, Kangolle A. Cancer control in developing countries: using health data and health services research to measure and improve access. Quality and efficiency. BMC Int Health Human Rights. 2010;10:24.
World Health Organization, working together for health: the world health report 2006 (Geneva, Switzerland, WHO, 2006).
Scheffler RM, Mahoney CB, Fulton BD, Dal Poz MR, Preker AS. Estimates of Health care professional shortages in Sub-Saharan Africa by 2015. Heath Aff. 2009;28(5):849–62.
UNAIDS, the Joint United Nations Programme. http://www.unaids.org. Accessed 28 Sept 2014.
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41:1–19.
Weiser TG, Regenbogen SE, Thompson EK, et al. An estimation of the global volume of surgery: a modeling strategy based on available data. Lancet. 2008;372:139–44.
Yii Mk, Ng KJ. Risk-adjusted surgical audit with the POSSUM scoring system in a developing country. Br J Surg. 2002;89:110–3.
Ouro-Bang’na Maman AF, Tomta K. Ahuaangbevi S, Chobli M. Deaths associated with anaesthesia in Togo, West Africa. Trop Doct. 2005:35:220–2.
Funk LM, Weiser TG, Berry WR, et al. Global operating theatre distribution and pulse oximetry supply: an estimation from reported Data. Lancet. 2010;376:1055–61.
Wairagala W. Working to improve access to palliative care in Africa. Lancet Oncol. 2010;11:227–8.
Yohana E, Kamuhabwa A, Mujinia P. Availability and affordability of anticancer medicines at the Ocean road Cancer Institute in Dar es Salaam, Tanzania. East Afr J Public Health. 2011;8(1):52–7.
Prevention of cervical cancer through screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy. World Health Organisation, Geneva, Switzerland; 2012.
De Sanjose S, Quint WGV, Alemany A, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048–56.
Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, et al. Human papillomavirus prevalence and type distribution in invasive cervical cancer in Sub-Saharan Africa. Int J Cancer. 2013;134(6):1389–98.
Denny L, Kuhn L, Hu CC, Tsai WY, Wright TC Jr. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial. J Natl Cancer Inst. 2010;102:1557–67.
Sankaranayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360(14):1385–94.
Kjaer SK, Sigurdsson K, Iversen O, et al. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (tyes 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res. 2009;02(10):868–78.
Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind randomized controlled trial. Lancet. 2007;369:2161–70.
Lu B, Kumar A, Castellsague X, Guiliano AR. Efficacy and safety of prophylactic vaccines against cervical HPV infection and disease among women. A systematic review and meta-analysis. BMC Infect Dis. 2011;11:13.
Ladner J, Besson M, Rodrigues M, Audureau E, Saba J. Performance of 21 HPV vaccination programs implemented in low and middle-income countries 2009 and 2013. BMC Public Health. 2014;14:670.
GAVI, the Vaccine Alliance. http://www.gavialliance.org. Accessed 28 Sept 2014.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Denny, L. Control of Cancer of the Cervix in Low- and Middle-Income Countries. Ann Surg Oncol 22, 728–733 (2015). https://doi.org/10.1245/s10434-014-4344-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-014-4344-8